Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Hospital del Mar Research Institute

Maria Grau, investigadora de l'IMIM, i José Miguel Baena-Díez. investigador de l'IDIAPJGol (Centre d'Atenció Primària La Marina), són els principals autors del treball.
14.08.2020

Covid-19 hits hardest the most deprived

GPCRs are the target of almost 40% of current drugs. Jana Selent's team has led the creation of a platform that facilitates their study.
20.07.2020

Facilitating drug design: a platform to study GPCRs

08.07.2020

MARBiobanc makes more than 2000 samples from COVID-19 patients available for research

The coronavirus pandemic has aggravated and increased the cases of mental health disorders in certain population groups. | Picture by Tumisu from Needpix.
29.06.2020

Two projects to study the impact of COVID-19 on mental health

We know that animals support people in difficult times, but this benefit has never been measured in a context where the whole population has been exposed to the same problem, on the scale of the COVID-19 epidemic. | Picture by Bruno Cervera from Unsplash.
23.06.2020

Companion animals have been key for emotional support during lockdown

Nearly half of the parets believe the physical and emotional health, as well as the quality of life of children will be affected after lockdown.
21.06.2020

Lockdown has affected the health of children in Spain

Joaquín Arribas became the new IMIM director in March 2020 - just in the midst of the coronavirus crisis.
09.06.2020

Joaquín Arribas (IMIM’s director): “We want to be the bridge between the research close to the patient and the PRBB high-tech”

PRBB residents at the 2019 OpenDay volunteers lunch.
29.05.2020

The PRBB remains stable regarding the latest demographic data

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.
22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

21.05.2020

Re-opening the labs

13.05.2020

Memory alterations described in mice with Down syndrome

Exceptional prevention measures are coming into effect for the entire PRBB community. These measures are accompanied by new signalling with clear messages. Following the measures, self-responsibility and respect for all residents will be key. | Picture by Albert Català.
12.05.2020

The PRBB gets ready for a phased comeback of its residents

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2025 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org